VBI Vaccines (VBIV) Provides an Update on its Restructuring Proceedings

Go back to VBI Vaccines (VBIV) Provides an Update on its Restructuring Proceedings

VBI Vaccines Provides an Update on its Restructuring Proceedings

August 2, 2024 4:05 PM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring proceedings announced on July 30, 2024.

U.S. Chapter 15 Filing
On August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S. Bankruptcy Code, and scheduled a further hearing to consider the recognition of the July 30, 2024, Ontario Superior Court of Justice (Commercial List) order (Initial Order), which granted the company... More